Chemical inhibitors of METTL23 function by interacting with various biochemical pathways and molecular interactions that are essential for the activity of this protein. Sinefungin, for instance, competes with S-adenosylmethionine (SAM), the usual methyl donor substrate of METTL23, by binding to the SAM-binding site that METTL23 relies on for its methylation activity. This competitive inhibition effectively blocks the protein's ability to transfer methyl groups to its substrates. Similarly, Cycloleucine acts as a competitive inhibitor of methionine adenosyltransferase, an enzyme critical for the synthesis of SAM. With reduced availability of SAM, the enzymatic activity of METTL23 is hindered. 3-Deazaneplanocin A and Adenosine dialdehyde function through a related mechanism by inhibiting S-adenosylhomocysteine hydrolase, causing the accumulation of S-adenosylhomocysteine, a strong inhibitor of SAM-dependent methyltransferases, including METTL23. This leads to a functional blockade of METTL23's methylation capacity.
Further, BIX-01294, although primarily known for its inhibitory effects on histone methyltransferases, could alter histone methylation patterns in such a way that the chromatin context necessary for METTL23's proper function is disrupted. RG108 and Decitabine exert an indirect inhibitory effect by altering the DNA methylation landscape, which can influence the expression and function of proteins that are crucial for METTL23's regulatory mechanisms. Hydralazine and Epigallocatechin gallate work similarly by inhibiting DNA methyltransferase activity, leading to changes in gene expression patterns that could subsequently inhibit METTL23. On the other hand, 5'-Methylthioadenosine (MTA) directly competes with SAM, thereby inhibiting METTL23. Quercetin impedes protein kinases that are involved in phosphorylation cascades essential for METTL23's activity. Lastly, Chaetocin targets histone methyltransferases, potentially affecting the regulation of METTL23 through changes in the chromatin state. Each of these chemicals targets specific molecular interactions and pathways that are central to the functional activity of METTL23, thereby serving as effective inhibitors of its function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Sinefungin | 58944-73-3 | sc-203263 sc-203263B sc-203263C sc-203263A | 1 mg 100 mg 1 g 10 mg | $266.00 $5100.00 $39576.00 $690.00 | 4 | |
Sinefungin, an analog of S-adenosylmethionine (SAM), can competitively inhibit METTL23 by occupying the SAM-binding site, thus preventing methylation reactions that METTL23 catalyzes. | ||||||
BIX01294 hydrochloride | 1392399-03-9 | sc-293525 sc-293525A sc-293525B | 1 mg 5 mg 25 mg | $36.00 $110.00 $400.00 | ||
BIX-01294 is known to inhibit histone methyltransferases and could indirectly inhibit METTL23 by altering histone methylation patterns that may be necessary for METTL23's proper function. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $128.00 $505.00 | 2 | |
RG108 inhibits DNA methyltransferases and may indirectly inhibit METTL23 by changing the methylation status of DNA, potentially affecting the expression of proteins that interact with or regulate METTL23. | ||||||
Adenosine, periodate oxidized | 34240-05-6 | sc-214510 sc-214510A | 25 mg 100 mg | $117.00 $357.00 | ||
This compound inhibits S-adenosylhomocysteine hydrolase, leading to increased levels of S-adenosylhomocysteine, which inhibits methyltransferases such as METTL23. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
By incorporating into DNA and inhibiting DNA methyltransferases, Decitabine alters DNA methylation patterns which can indirectly inhibit METTL23 by affecting the transcription of proteins that regulate METTL23 activity. | ||||||
Hydralazine-15N4 Hydrochloride | 304-20-1 (unlabeled) | sc-490605 | 1 mg | $480.00 | ||
Hydralazine inhibits DNA methyltransferase activity, potentially altering gene expression patterns of proteins that regulate or interact with METTL23, thereby indirectly inhibiting its function. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
Epigallocatechin gallate can inhibit DNA methyltransferases and might indirectly inhibit METTL23 by changing the methylation status of genes that regulate or interact with METTL23. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $108.00 $245.00 $918.00 $49.00 | 33 | |
Quercetin has been shown to inhibit protein kinases which could indirectly inhibit METTL23 by disrupting phosphorylation-dependent signaling pathways that regulate METTL23 activity. | ||||||
Chaetocin | 28097-03-2 | sc-200893 | 200 µg | $120.00 | 5 | |
Chaetocin is a known inhibitor of histone methyltransferases. It may indirectly inhibit METTL23 by altering histone methylation patterns, potentially affecting the chromatin state and regulation of METTL23. | ||||||